The high incidence of expression of TGF-β, IL-8, IL-6, VEGF, PDGF-AA, OPN, IGF-1 and IL-15 by human melanoma supports consideration of these factors in future planning of therapy. This evidence concerns the gene CXCL8 and melanoma.